Google, Microsoft May Pose Threats to Patient Privacy


By Maureen McKinney

April 22, 2008 | The entry of corporate behemoths like Google and Microsoft into the health information industry could have fundamental impacts on patient privacy, as well as on clinical research, according to an April 17 article in the New England Journal of Medicine.

The article, entitled, “Tectonic Shifts in the Health Information Economy,” differentiated personally controlled health records (PCHRs) from basic personal health records because PCHRs place primary control of data use and disclosure in the hands of patients. The authors cited the need for collaboration among PCHR providers, academic medical centers and the government in order to reach a consensus about appropriate methods of preserving data security and conducting research.

“Giving someone access to data that is institutionally controlled may have some benefits for the patient including insight into their own care, but with PCHRs, we go well beyond the walls of the institution,” explained Kenneth Mandl, associate professor at Children’s Hospital Boston, and co-author of the article. “Patients can engage with other institutions and entities, while the data flows into a repository that is exclusively controlled by the patient.”

One major concern with this dramatic increase in data liquidity, said Mandl, is that corporate entities entering the personal health record field are not held to the same standards as an academic research institution. Because companies like Google currently say they do not have to comply with the requirements and safeguards of the Health Insurance Portability and Accountability Act (HIPAA), there is no indication if they will adhere to research standards, he said.

“Under HIPAA, if one is to do research, they go before an institutional review board, which operates under the federal government and reviews protocols on how the data should be used,” Mandl said. “There are restrictions as far as aggregating patient data, benefits, risks, and notification. That’s a clear system of oversight, but with PCHRs, data from the repositories may be used for various kinds of research including drug approval and marketing.”

In addition, Mandl said, academic research centers may be at a disadvantage because not only do they have to comply with HIPAA protocols, they also might not have access to patient data pools as large as those of HealthVault and Google. If the largest and most complete databases reside on PCHR servers, it prompts questions about those companies’ research missions, the authors said.

In one example scenario provided in the article, a patient grants PCHR access to a clinical trial of a new medication, a medical social networking site, and an government-sponsored postmarketing surveillance program—none of which provide any informational control to medical centers.

“There is a reasonable argument that such control has been parochial and has created inefficiencies in fostering scientific discoveries and in delivering high-quality clinical care,” the authors said. “Nonetheless, if the pendulum swings the other way, and entire generation of clinical researchers in training will find themselves with second-class or no access to the best research resources.”

Patient privacy in PCHRs also remains uncertain and depends largely on how the hosting services of these companies approach the issue and inform their clients about the risks of certain types of disclosures, said Isaac Kohane, associate professor at Children’s Hospital Boston, director of the hospital’s informatics program, and co-author of the article.

Mandl and Kohane cited several critical steps that must be taken in order for PCHRs to be effective including the free exchange of patient data using agreed-upon standards, greater adoption of electronic health records, and new methods for protecting identity and security.

“Frankly, we don’t know what the optimal way is right now,” said Mandl. “We do think patients deserve guideposts, so we need to find the right mix that encourages discovery and, at the same time, protects the individual. That’s a conversation that PCHR service providers and medical centers need to be having.”

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .